Materials
| Name | Company | Catalog Number | Comments |
| LDLR-deficient mice (D2.129S7(B6)-Ldlrtm1Her/J) | The Jackson Laboratory | stock #002207 | |
| Formalin | Sigma-Aldrich | HT5011 | |
| Histology Molds | Ted Pella Inc | 27195 | |
| Paraffin | Paramat | 19286-10 | |
| Coated slides | Fisher | 12-550-15 | |
| Solvent containers | Tissue Tek II | 4457 | |
| Microtome | Leica | RM22S5 | |
| Water bath | VWR | 80086-982 | |
| Microscope | Olympus | BX41TF | |
| Camera | Olympus | DP72 | |
| ImageJ | NIH | www.rsbweb.nih.gov/ij/ | |
| Processor | Sakura Finetek | VIP6-A1 | |
| Processing cassettes | VWR | 18000-134 | |
| Preassure Cooker | Nordic Ware | ||
| Coverslip | Fisher | 12-545-M | |
| PBS | Sigma-Aldrich | P3813 | |
| Microtome blade | Thermo Scientific | 30-518-35 | |
| Antifade mounting medium | Sigma-Aldrich | F-4680 | |
| Xylene mounting medium | Sigma-Aldrich | 44581 | |
| Aquous mounting medium | Sigma-Aldrich | I1161 | |
| Mac-3 anbody | BD Pharmingen | 553322 | |
| DAPI | Sigma-Aldrich | D9542 | |
| F4/80 antibody | Abcam | Ab6640 | |
| Alpha actin antibody | Santa Cruz Biotechnology | SC-32251 | |
| Mayer’s Hematoxylin | Sigma-Aldrich | E4382 | |
| Eosin Y | Sigma-Aldrich | MHS16 | |
| DAB (3,3'-Diaminobenzidine) | Dako | K3468 |
References
- Zadelaar, S., Kleemann, R., et al. Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler. Thromb. Vasc. Biol. 27 (8), 1706-1721 (2007).
- Daugherty, A., Rateri, D. L. Development of experimental designs for atherosclerosis studies in mice. Methods. 36, 129-138 (2005).
- Getz, G. S., Reardon, C. A.
- Zhang, S. H., Reddick, R. L., et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258 (5081), 468-471 (1992).
- Ishibashi, S., Goldstein, J. L., et al. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93 (5), 1885-1893 (1994).
- Kunjathoor, V. V., Wilson, D. L., LeBoeuf, R. C. Increased atherosclerosis in streptozotocin-induced diabetic mice. J. Clin. Invest. 97 (7), 1767-1773 (1996).
- Hartvigsen, K., Binder, C. J., et al. A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 27 (4), 878-885 (2007).
- King, V. L., Hatch, N. W., et al. A murine model of obesity with accelerated atherosclerosis. Obesity. 18 (1), 35-41 (2004).
- Taylor Weiss, D. &, R, W. Deoxycorticosterone acetate salt hypertension in apolipoprotein E-/- mice results in accelerated atherosclerosis: the role of angiotensin II. Hypertension. 51 (2), 218-224 (2008).
- Gairola, C. G., Drawdy, M. L., et al. Sidestream cigarette smoke accelerates atherogenesis in apolipoprotein E-/- mice. Atherosclerosis. 156 (1), 49-55 (2001).
- Pynn, M., Schäfer, K., et al. Exercise training reduces neointimal growth and stabilizes vascular lesions developing after injury in apolipoprotein e-deficient mice. Circulation. 109 (3), 386-392 (2004).
- Nakashima, Y., Plump, A. S., et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14 (1), 133-140 (1994).
- Reddick, R. L., Zhang, S. H., Maeda, N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler. Thromb. 14 (1), 141-147 (1994).
- Tangirala, R. K., Rubin, E. M., Palinski, W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid Res. 36 (11), 2320-2328 (1995).
- Paigen, B., Morrow, A., et al. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68 (3), 231-240 (1987).
- Baglione, J., Smith, J. D. Quantitative Assay for Mouse Atherosclerosis in the Aortic Root. Methods in Molecular Medicine. 129, (2006).
- Lee, T. Y., Muschal, S., et al. Angiostatin regulates the expression of antiangiogenic and proapoptotic pathways via targeted inhibition of mitochondrial proteins. Blood. 114 (9), 1987-1998 (2009).
- Ballon, G., Chen, K., et al. Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice. J. Clin. Invest. 121 (3), 1141-1153 (2011).
- Khallou-Laschet, J., Varthaman, A., et al.
- Rotzius, P., Thams, S., et al. Distinct infiltration of neutrophils in lesion shoulders in ApoE-/- mice. Am. J. Pathol. 177 (1), 493-500 (2010).
- Kanellakis, P., Agrotis, A., et al. High-mobility group box protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein e-deficient mice. Arterioscler. Thromb. Vasc. Biol. 31 (2), 313-319 (2011).
- Schwartz, C. J., Mitchell, J. R. Observations on localization of arterial plaques. Circ. Res. 11, 63-73 (1962).
- Won, D., Zhu, S. N., Chen, M., et al. Relative reduction of endothelial nitric-oxide synthase expression and transcription in atherosclerosis-prone regions of the mouse aorta and in an in vitro model of disturbed flow. Am. J. Pathol. 171 (5), 1691-1704 (2007).
- Rosenfeld, M. E., Polinsky, P., et al. Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler. Thromb. Vasc. Biol. 20 (12), 2587-2592 (2000).
- McAteer, M. A., Schneider, J. E., et al. Quantification and 3Dreconstruction of atherosclerotic plaque components in apolipoprotein E knockout mice using ex vivo high-resolution MRI. Arterioscler. Thromb. Vasc. Biol. 24 (12), 2384-2390 (2004).
- Martinez, H. G., Prajapati, S. I., et al. Images in cardiovascular medicine: Microscopiccomputedtomography-based virtual histology for visualization and morphometry of atherosclerosis in diabetic apolipoprotein e mutant mice. Circulation. 120 (9), 821-822 (2009).
- Kirkby, N. S., Low, L., et al. Quantitative 3-dimensional imaging of murine neointimal and atherosclerotic lesions by optical projection tomography. PLoS One. 6 (2), e16906 (2011).
